1	2	_	_	CD	_	_	_	_	_
2	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	Role	_	_	NNP	_	_	_	_	_
3	of	_	_	IN	_	_	_	_	_
4	the	_	_	DT	_	_	_	_	_
5	bHLH	_	_	NNP	_	_	_	_	_
6	Proteins	_	_	NNS	_	_	_	_	_
7	in	_	_	IN	_	_	_	_	_
8	Transcription	_	_	NN	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	regulation	_	_	NN	_	_	_	_	_
3	of	_	_	IN	_	_	_	_	_
4	genes	_	_	NNS	_	_	_	_	_
5	expression	_	_	NN	_	_	_	_	_
6	by	_	_	IN	_	_	_	_	_
7	multiple	_	_	JJ	_	_	_	_	_
8	transcription	_	_	NN	_	_	_	_	_
9	factors	_	_	NNS	_	_	_	_	_
10	,	_	_	,	_	_	_	_	_
11	cofactors	_	_	NNS	_	_	_	_	_
12	and	_	_	CC	_	_	_	_	_
13	chromatin	_	_	NN	_	_	_	_	_
14	regulators	_	_	NNS	_	_	_	_	_
15	establish	_	_	VBP	_	_	_	_	_
16	and	_	_	CC	_	_	_	_	_
17	maintains	_	_	VBZ	_	_	_	_	_
18	a	_	_	DT	_	_	_	_	_
19	specific	_	_	JJ	_	_	_	_	_
20	state	_	_	NN	_	_	_	_	_
21	of	_	_	IN	_	_	_	_	_
22	a	_	_	DT	_	_	_	_	_
23	cell	_	_	NN	_	_	_	_	_
24	.	_	_	.	_	_	_	_	_


1	Inaccurate	_	_	JJ	_	_	_	_	_
2	regulation	_	_	NN	_	_	_	_	_
3	of	_	_	IN	_	_	_	_	_
4	transmitted	_	_	VBN	_	_	_	_	_
5	signals	_	_	NNS	_	_	_	_	_
6	can	_	_	MD	_	_	_	_	_
7	results	_	_	VBZ	_	_	_	_	_
8	in	_	_	IN	_	_	_	_	_
9	diseases	_	_	NNS	_	_	_	_	_
10	and	_	_	CC	_	_	_	_	_
11	severe	_	_	JJ	_	_	_	_	_
12	disorders	_	_	NNS	_	_	_	_	_
13	.	_	_	.	_	_	_	_	_


1	Therefore	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	transcription	_	_	NN	_	_	_	_	_
4	requires	_	_	VBZ	_	_	_	_	_
5	balanced	_	_	JJ	_	_	_	_	_
6	orchestration	_	_	NN	_	_	_	_	_
7	of	_	_	IN	_	_	_	_	_
8	adjustable	_	_	JJ	_	_	_	_	_
9	complexes	_	_	NNS	_	_	_	_	_
10	of	_	_	IN	_	_	_	_	_
11	proteins	_	_	NNS	_	_	_	_	_
12	.	_	_	.	_	_	_	_	_


1	A	_	_	DT	_	_	_	_	_
2	key	_	_	JJ	_	_	_	_	_
3	regulator	_	_	NN	_	_	_	_	_
4	of	_	_	IN	_	_	_	_	_
5	transcription	_	_	NN	_	_	_	_	_
6	is	_	_	VBZ	_	_	_	_	_
7	Mediator	_	_	NNP	_	_	_	_	_
8	,	_	_	,	_	_	_	_	_
9	a	_	_	DT	_	_	_	_	_
10	multi-subunit	_	_	JJ	_	_	_	_	_
11	Mediator	_	_	NN	_	_	_	_	_
12	complex	_	_	NN	_	_	_	_	_
13	which	_	_	WDT	_	_	_	_	_
14	interacts	_	_	VBZ	_	_	_	_	_
15	with	_	_	IN	_	_	_	_	_
16	RNA	_	_	NN	_	_	_	_	_
17	polymerase	_	_	NN	_	_	_	_	_
18	II	_	_	NNP	_	_	_	_	_
19	(	_	_	-LRB-	_	_	_	_	_
20	Pol	_	_	NNP	_	_	_	_	_
21	II	_	_	NNP	_	_	_	_	_
22	)	_	_	-RRB-	_	_	_	_	_
23	,	_	_	,	_	_	_	_	_
24	and	_	_	CC	_	_	_	_	_
25	coordinates	_	_	VBZ	_	_	_	_	_
26	the	_	_	DT	_	_	_	_	_
27	action	_	_	NN	_	_	_	_	_
28	of	_	_	IN	_	_	_	_	_
29	numerous	_	_	JJ	_	_	_	_	_
30	co-activators	_	_	NNS	_	_	_	_	_
31	and	_	_	CC	_	_	_	_	_
32	co-repressors	_	_	NNS	_	_	_	_	_
33	.	_	_	.	_	_	_	_	_


1	Function	_	_	NN	_	_	_	_	_
2	of	_	_	IN	_	_	_	_	_
3	the	_	_	DT	_	_	_	_	_
4	Mediator	_	_	NN	_	_	_	_	_
5	is	_	_	VBZ	_	_	_	_	_
6	conserved	_	_	VBN	_	_	_	_	_
7	in	_	_	IN	_	_	_	_	_
8	all	_	_	DT	_	_	_	_	_
9	eukaryotes	_	_	NNS	_	_	_	_	_
10	,	_	_	,	_	_	_	_	_
11	though	_	_	RB	_	_	_	_	_
12	,	_	_	,	_	_	_	_	_
13	the	_	_	DT	_	_	_	_	_
14	individual	_	_	JJ	_	_	_	_	_
15	subunits	_	_	NNS	_	_	_	_	_
16	have	_	_	VBP	_	_	_	_	_
17	diverged	_	_	VBN	_	_	_	_	_
18	considerably	_	_	RB	_	_	_	_	_
19	in	_	_	IN	_	_	_	_	_
20	some	_	_	DT	_	_	_	_	_
21	organisms	_	_	NNS	_	_	_	_	_
22	.	_	_	.	_	_	_	_	_


1	Up	_	_	IN	_	_	_	_	_
2	to	_	_	TO	_	_	_	_	_
3	date	_	_	NN	_	_	_	_	_
4	,	_	_	,	_	_	_	_	_
5	for	_	_	IN	_	_	_	_	_
6	some	_	_	DT	_	_	_	_	_
7	bHLH	_	_	NNP	_	_	_	_	_
8	family	_	_	NN	_	_	_	_	_
9	representatives	_	_	NNS	_	_	_	_	_
10	,	_	_	,	_	_	_	_	_
11	interactions	_	_	NNS	_	_	_	_	_
12	with	_	_	IN	_	_	_	_	_
13	subunits	_	_	NNS	_	_	_	_	_
14	of	_	_	IN	_	_	_	_	_
15	the	_	_	DT	_	_	_	_	_
16	Mediator	_	_	NNP	_	_	_	_	_
17	and/or	_	_	NNP	_	_	_	_	_
18	chromatin	_	_	NN	_	_	_	_	_
19	remodeling	_	_	VBG	_	_	_	_	_
20	histone	_	_	NN	_	_	_	_	_
21	acetyltransferases/deacyltransferase	_	_	NN	_	_	_	_	_
22	,	_	_	,	_	_	_	_	_
23	were	_	_	VBD	_	_	_	_	_
24	reported	_	_	VBN	_	_	_	_	_
25	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	plants	_	_	NNS	_	_	_	_	_
3	,	_	_	,	_	_	_	_	_
4	the	_	_	DT	_	_	_	_	_
5	Mediator	_	_	NNP	_	_	_	_	_
6	complex	_	_	NN	_	_	_	_	_
7	is	_	_	VBZ	_	_	_	_	_
8	a	_	_	DT	_	_	_	_	_
9	core	_	_	JJ	_	_	_	_	_
10	element	_	_	NN	_	_	_	_	_
11	of	_	_	IN	_	_	_	_	_
12	transcription	_	_	NN	_	_	_	_	_
13	regulation	_	_	NN	_	_	_	_	_
14	important	_	_	JJ	_	_	_	_	_
15	for	_	_	IN	_	_	_	_	_
16	their	_	_	PRP$	_	_	_	_	_
17	immunity	_	_	NN	_	_	_	_	_
18	.	_	_	.	_	_	_	_	_


1	It	_	_	PRP	_	_	_	_	_
2	was	_	_	VBD	_	_	_	_	_
3	shown	_	_	VBN	_	_	_	_	_
4	,	_	_	,	_	_	_	_	_
5	that	_	_	IN	_	_	_	_	_
6	in	_	_	IN	_	_	_	_	_
7	Arabidopsis	_	_	NNP	_	_	_	_	_
8	thaliana	_	_	NN	_	_	_	_	_
9	important	_	_	JJ	_	_	_	_	_
10	jasmonate	_	_	NN	_	_	_	_	_
11	signaling	_	_	NN	_	_	_	_	_
12	and	_	_	CC	_	_	_	_	_
13	resistance	_	_	NN	_	_	_	_	_
14	to	_	_	TO	_	_	_	_	_
15	fungus	_	_	NN	_	_	_	_	_
16	Botrytis	_	_	FW	_	_	_	_	_
17	cinerea	_	_	FW	_	_	_	_	_
18	,	_	_	,	_	_	_	_	_
19	is	_	_	VBZ	_	_	_	_	_
20	dependent	_	_	VBN	_	_	_	_	_
21	on	_	_	IN	_	_	_	_	_
22	the	_	_	DT	_	_	_	_	_
23	interaction	_	_	NN	_	_	_	_	_
24	between	_	_	IN	_	_	_	_	_
25	MED25	_	_	NNP	_	_	_	_	_
26	subunit	_	_	NN	_	_	_	_	_
27	of	_	_	IN	_	_	_	_	_
28	the	_	_	DT	_	_	_	_	_
29	Mediator	_	_	NNP	_	_	_	_	_
30	and	_	_	CC	_	_	_	_	_
31	MYC2	_	_	NNP	_	_	_	_	_
32	,	_	_	,	_	_	_	_	_
33	and	_	_	CC	_	_	_	_	_
34	interaction	_	_	NN	_	_	_	_	_
35	of	_	_	IN	_	_	_	_	_
36	MED8	_	_	NNP	_	_	_	_	_
37	subunit	_	_	NN	_	_	_	_	_
38	of	_	_	IN	_	_	_	_	_
39	the	_	_	DT	_	_	_	_	_
40	Mediator	_	_	NNP	_	_	_	_	_
41	with	_	_	IN	_	_	_	_	_
42	FAMA	_	_	NNP	_	_	_	_	_
43	belonging	_	_	VBG	_	_	_	_	_
44	to	_	_	TO	_	_	_	_	_
45	the	_	_	DT	_	_	_	_	_
46	bHLH	_	_	NNP	_	_	_	_	_
47	family	_	_	NN	_	_	_	_	_
48	.	_	_	.	_	_	_	_	_


1	Sterol	_	_	NN	_	_	_	_	_
2	regulatory	_	_	JJ	_	_	_	_	_
3	element	_	_	NN	_	_	_	_	_
4	binding	_	_	NN	_	_	_	_	_
5	proteins	_	_	NNS	_	_	_	_	_
6	(	_	_	-LRB-	_	_	_	_	_
7	SREBPs	_	_	NNS	_	_	_	_	_
8	)	_	_	-RRB-	_	_	_	_	_
9	the	_	_	DT	_	_	_	_	_
10	class	_	_	NN	_	_	_	_	_
11	II	_	_	NNP	_	_	_	_	_
12	bHLH	_	_	NN	_	_	_	_	_
13	TFs	_	_	NNP	_	_	_	_	_
14	(	_	_	-LRB-	_	_	_	_	_
15	Table	_	_	NN	_	_	_	_	_
16	1	_	_	CD	_	_	_	_	_
17	)	_	_	-RRB-	_	_	_	_	_
18	are	_	_	VBP	_	_	_	_	_
19	transcription	_	_	NN	_	_	_	_	_
20	activators	_	_	NNS	_	_	_	_	_
21	critical	_	_	JJ	_	_	_	_	_
22	for	_	_	IN	_	_	_	_	_
23	regulation	_	_	NN	_	_	_	_	_
24	of	_	_	IN	_	_	_	_	_
25	cholesterol	_	_	NN	_	_	_	_	_
26	and	_	_	CC	_	_	_	_	_
27	fatty	_	_	NN	_	_	_	_	_
28	acid	_	_	NN	_	_	_	_	_
29	homeostasis	_	_	NN	_	_	_	_	_
30	in	_	_	IN	_	_	_	_	_
31	animals	_	_	NNS	_	_	_	_	_
32	.	_	_	.	_	_	_	_	_


1	It	_	_	PRP	_	_	_	_	_
2	was	_	_	VBD	_	_	_	_	_
3	shown	_	_	VBN	_	_	_	_	_
4	that	_	_	IN	_	_	_	_	_
5	human	_	_	JJ	_	_	_	_	_
6	SREBPs	_	_	NNS	_	_	_	_	_
7	bind	_	_	VBP	_	_	_	_	_
8	CBP/p300	_	_	NN	_	_	_	_	_
9	acetyltransferase	_	_	NN	_	_	_	_	_
10	and	_	_	CC	_	_	_	_	_
11	MED15	_	_	NNP	_	_	_	_	_
12	subunit	_	_	NN	_	_	_	_	_
13	of	_	_	IN	_	_	_	_	_
14	the	_	_	DT	_	_	_	_	_
15	Mediator	_	_	NN	_	_	_	_	_
16	to	_	_	TO	_	_	_	_	_
17	activate	_	_	VB	_	_	_	_	_
18	target	_	_	NN	_	_	_	_	_
19	genes	_	_	NNS	_	_	_	_	_
20	.	_	_	.	_	_	_	_	_


1	Also	_	_	RB	_	_	_	_	_
2	yeast	_	_	NN	_	_	_	_	_
3	Ino2	_	_	NNP	_	_	_	_	_
4	was	_	_	VBD	_	_	_	_	_
5	shown	_	_	VBN	_	_	_	_	_
6	to	_	_	TO	_	_	_	_	_
7	bind	_	_	VB	_	_	_	_	_
8	MED15	_	_	NNP	_	_	_	_	_
9	subunit	_	_	NN	_	_	_	_	_
10	of	_	_	IN	_	_	_	_	_
11	the	_	_	DT	_	_	_	_	_
12	Mediator	_	_	NNP	_	_	_	_	_
13	tail	_	_	NN	_	_	_	_	_
14	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	representative	_	_	NN	_	_	_	_	_
3	of	_	_	IN	_	_	_	_	_
4	class	_	_	NN	_	_	_	_	_
5	II	_	_	NNP	_	_	_	_	_
6	TFs	_	_	NNP	_	_	_	_	_
7	TAL1	_	_	NNP	_	_	_	_	_
8	(	_	_	-LRB-	_	_	_	_	_
9	Table	_	_	NN	_	_	_	_	_
10	1	_	_	CD	_	_	_	_	_
11	)	_	_	-RRB-	_	_	_	_	_
12	is	_	_	VBZ	_	_	_	_	_
13	required	_	_	VBN	_	_	_	_	_
14	for	_	_	IN	_	_	_	_	_
15	the	_	_	DT	_	_	_	_	_
16	specification	_	_	NN	_	_	_	_	_
17	of	_	_	IN	_	_	_	_	_
18	the	_	_	DT	_	_	_	_	_
19	blood	_	_	NN	_	_	_	_	_
20	lineage	_	_	NN	_	_	_	_	_
21	and	_	_	CC	_	_	_	_	_
22	maturation	_	_	NN	_	_	_	_	_
23	of	_	_	IN	_	_	_	_	_
24	several	_	_	JJ	_	_	_	_	_
25	hematopoietic	_	_	JJ	_	_	_	_	_
26	cells	_	_	NNS	_	_	_	_	_
27	.	_	_	.	_	_	_	_	_


1	TAL1/SCL	_	_	NNP	_	_	_	_	_
2	is	_	_	VBZ	_	_	_	_	_
3	considered	_	_	VBN	_	_	_	_	_
4	as	_	_	IN	_	_	_	_	_
5	a	_	_	DT	_	_	_	_	_
6	master	_	_	NN	_	_	_	_	_
7	TF	_	_	NN	_	_	_	_	_
8	delineating	_	_	VBG	_	_	_	_	_
9	the	_	_	DT	_	_	_	_	_
10	cell	_	_	NN	_	_	_	_	_
11	fate	_	_	NN	_	_	_	_	_
12	and	_	_	CC	_	_	_	_	_
13	the	_	_	DT	_	_	_	_	_
14	identity	_	_	NN	_	_	_	_	_
15	of	_	_	IN	_	_	_	_	_
16	progenitor	_	_	NN	_	_	_	_	_
17	and	_	_	CC	_	_	_	_	_
18	normal	_	_	JJ	_	_	_	_	_
19	hematopoietic	_	_	JJ	_	_	_	_	_
20	stem	_	_	NN	_	_	_	_	_
21	cells	_	_	NNS	_	_	_	_	_
22	(	_	_	-LRB-	_	_	_	_	_
23	HSCs	_	_	NNPS	_	_	_	_	_
24	)	_	_	-RRB-	_	_	_	_	_
25	.	_	_	.	_	_	_	_	_


1	It	_	_	PRP	_	_	_	_	_
2	regulates	_	_	VBZ	_	_	_	_	_
3	other	_	_	JJ	_	_	_	_	_
4	hematopoietic	_	_	JJ	_	_	_	_	_
5	TFs	_	_	NNS	_	_	_	_	_
6	thus	_	_	RB	_	_	_	_	_
7	has	_	_	VBZ	_	_	_	_	_
8	a	_	_	DT	_	_	_	_	_
9	potential	_	_	NN	_	_	_	_	_
10	for	_	_	IN	_	_	_	_	_
11	cell	_	_	NN	_	_	_	_	_
12	reprogramming	_	_	NN	_	_	_	_	_
13	.	_	_	.	_	_	_	_	_


1	TAL1	_	_	NNP	_	_	_	_	_
2	also	_	_	RB	_	_	_	_	_
3	binds	_	_	VBZ	_	_	_	_	_
4	CBP/p300	_	_	NNP	_	_	_	_	_
5	acetyltransferase	_	_	NN	_	_	_	_	_
6	.	_	_	.	_	_	_	_	_


1	Similarly	_	_	RB	_	_	_	_	_
2	MyoD	_	_	NNP	_	_	_	_	_
3	â€”	_	_	:	_	_	_	_	_
4	a	_	_	DT	_	_	_	_	_
5	myogenic	_	_	JJ	_	_	_	_	_
6	regulatory	_	_	JJ	_	_	_	_	_
7	factor	_	_	NN	_	_	_	_	_
8	which	_	_	WDT	_	_	_	_	_
9	controls	_	_	VBZ	_	_	_	_	_
10	skeletal	_	_	JJ	_	_	_	_	_
11	muscle	_	_	NN	_	_	_	_	_
12	development	_	_	NN	_	_	_	_	_
13	binds	_	_	VBZ	_	_	_	_	_
14	CBP	_	_	NN	_	_	_	_	_
15	and	_	_	CC	_	_	_	_	_
16	recruits	_	_	NNS	_	_	_	_	_
17	histone	_	_	NN	_	_	_	_	_
18	acetyltransferase	_	_	NN	_	_	_	_	_
19	to	_	_	TO	_	_	_	_	_
20	activate	_	_	VB	_	_	_	_	_
21	myogenic	_	_	JJ	_	_	_	_	_
22	program	_	_	NN	_	_	_	_	_
23	.	_	_	.	_	_	_	_	_
24	Cao	_	_	NNP	_	_	_	_	_
25	et	_	_	FW	_	_	_	_	_
26	al.	_	_	FW	_	_	_	_	_
27	showed	_	_	VBD	_	_	_	_	_
28	that	_	_	IN	_	_	_	_	_
29	of	_	_	IN	_	_	_	_	_
30	MyoD	_	_	NNP	_	_	_	_	_
31	modify	_	_	VB	_	_	_	_	_
32	the	_	_	DT	_	_	_	_	_
33	myoblasts	_	_	NNS	_	_	_	_	_
34	chromatin	_	_	NN	_	_	_	_	_
35	structure	_	_	NN	_	_	_	_	_
36	and	_	_	CC	_	_	_	_	_
37	accessibility	_	_	NN	_	_	_	_	_
38	.	_	_	.	_	_	_	_	_
39	ASCL1	_	_	NN	_	_	_	_	_
40	(	_	_	-LRB-	_	_	_	_	_
41	class	_	_	NN	_	_	_	_	_
42	II	_	_	NNP	_	_	_	_	_
43	,	_	_	,	_	_	_	_	_
44	Table	_	_	NN	_	_	_	_	_
45	1	_	_	CD	_	_	_	_	_
46	)	_	_	-RRB-	_	_	_	_	_
47	was	_	_	VBD	_	_	_	_	_
48	shown	_	_	VBN	_	_	_	_	_
49	to	_	_	TO	_	_	_	_	_
50	be	_	_	VB	_	_	_	_	_
51	a	_	_	DT	_	_	_	_	_
52	pioneer	_	_	NN	_	_	_	_	_
53	factor	_	_	NN	_	_	_	_	_
54	which	_	_	WDT	_	_	_	_	_
55	promotes	_	_	VBZ	_	_	_	_	_
56	chromatin	_	_	NN	_	_	_	_	_
57	accessibility	_	_	NN	_	_	_	_	_
58	and	_	_	CC	_	_	_	_	_
59	enables	_	_	VBZ	_	_	_	_	_
60	chromatin	_	_	NN	_	_	_	_	_
61	binding	_	_	NN	_	_	_	_	_
62	by	_	_	IN	_	_	_	_	_
63	others	_	_	NNS	_	_	_	_	_
64	TFs	_	_	NNS	_	_	_	_	_
65	.	_	_	.	_	_	_	_	_


1	Recently	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	also	_	_	RB	_	_	_	_	_
4	AHR	_	_	NNP	_	_	_	_	_
5	(	_	_	-LRB-	_	_	_	_	_
6	bHLH-PAS	_	_	NNP	_	_	_	_	_
7	,	_	_	,	_	_	_	_	_
8	Table	_	_	NN	_	_	_	_	_
9	1	_	_	CD	_	_	_	_	_
10	)	_	_	-RRB-	_	_	_	_	_
11	was	_	_	VBD	_	_	_	_	_
12	suggested	_	_	VBN	_	_	_	_	_
13	to	_	_	TO	_	_	_	_	_
14	be	_	_	VB	_	_	_	_	_
15	a	_	_	DT	_	_	_	_	_
16	pioneer	_	_	NN	_	_	_	_	_
17	factor	_	_	NN	_	_	_	_	_
18	which	_	_	WDT	_	_	_	_	_
19	regulates	_	_	VBZ	_	_	_	_	_
20	DNA	_	_	NN	_	_	_	_	_
21	methylation	_	_	NN	_	_	_	_	_
22	during	_	_	IN	_	_	_	_	_
23	embryonic	_	_	JJ	_	_	_	_	_
24	developments	_	_	NNS	_	_	_	_	_
25	in	_	_	IN	_	_	_	_	_
26	unknown	_	_	JJ	_	_	_	_	_
27	way	_	_	NN	_	_	_	_	_
28	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	clear	_	_	JJ	_	_	_	_	_
3	cell	_	_	NN	_	_	_	_	_
4	renal	_	_	JJ	_	_	_	_	_
5	cell	_	_	NN	_	_	_	_	_
6	carcinoma	_	_	NN	_	_	_	_	_
7	(	_	_	-LRB-	_	_	_	_	_
8	ccRCC	_	_	NN	_	_	_	_	_
9	)	_	_	-RRB-	_	_	_	_	_
10	,	_	_	,	_	_	_	_	_
11	the	_	_	DT	_	_	_	_	_
12	most	_	_	RBS	_	_	_	_	_
13	frequent	_	_	JJ	_	_	_	_	_
14	mutation	_	_	NN	_	_	_	_	_
15	causes	_	_	VBZ	_	_	_	_	_
16	the	_	_	DT	_	_	_	_	_
17	von	_	_	NNP	_	_	_	_	_
18	Hippel-Lindau	_	_	NNP	_	_	_	_	_
19	(	_	_	-LRB-	_	_	_	_	_
20	VHL	_	_	NNP	_	_	_	_	_
21	)	_	_	-RRB-	_	_	_	_	_
22	tumor	_	_	NN	_	_	_	_	_
23	suppressor	_	_	NN	_	_	_	_	_
24	inactivation	_	_	NN	_	_	_	_	_
25	leading	_	_	VBG	_	_	_	_	_
26	to	_	_	TO	_	_	_	_	_
27	genome-wide	_	_	JJ	_	_	_	_	_
28	enhancer	_	_	NN	_	_	_	_	_
29	and	_	_	CC	_	_	_	_	_
30	super-enhancer	_	_	NN	_	_	_	_	_
31	remodeling	_	_	NN	_	_	_	_	_
32	.	_	_	.	_	_	_	_	_


1	This	_	_	DT	_	_	_	_	_
2	process	_	_	NN	_	_	_	_	_
3	is	_	_	VBZ	_	_	_	_	_
4	mediated	_	_	VBN	_	_	_	_	_
5	by	_	_	IN	_	_	_	_	_
6	the	_	_	DT	_	_	_	_	_
7	interaction	_	_	NN	_	_	_	_	_
8	of	_	_	IN	_	_	_	_	_
9	HIF2Î±	_	_	NN	_	_	_	_	_
10	and	_	_	CC	_	_	_	_	_
11	HIF1Î²	_	_	NNP	_	_	_	_	_
12	(	_	_	-LRB-	_	_	_	_	_
13	bHLH-PAS	_	_	NNP	_	_	_	_	_
14	,	_	_	,	_	_	_	_	_
15	Table	_	_	NN	_	_	_	_	_
16	1	_	_	CD	_	_	_	_	_
17	)	_	_	-RRB-	_	_	_	_	_
18	with	_	_	IN	_	_	_	_	_
19	histone	_	_	NN	_	_	_	_	_
20	acetyltransferase	_	_	NN	_	_	_	_	_
21	p300	_	_	NN	_	_	_	_	_
22	.	_	_	.	_	_	_	_	_


1	CLOCK	_	_	NNP	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	the	_	_	DT	_	_	_	_	_
4	other	_	_	JJ	_	_	_	_	_
5	bHLH-PAS	_	_	NNP	_	_	_	_	_
6	subfamily	_	_	NN	_	_	_	_	_
7	member	_	_	NN	_	_	_	_	_
8	(	_	_	-LRB-	_	_	_	_	_
9	Table	_	_	NNP	_	_	_	_	_
10	1	_	_	CD	_	_	_	_	_
11	)	_	_	-RRB-	_	_	_	_	_
12	was	_	_	VBD	_	_	_	_	_
13	shown	_	_	VBN	_	_	_	_	_
14	to	_	_	TO	_	_	_	_	_
15	mediate	_	_	VB	_	_	_	_	_
16	histone	_	_	NN	_	_	_	_	_
17	acetylation	_	_	NN	_	_	_	_	_
18	in	_	_	IN	_	_	_	_	_
19	a	_	_	DT	_	_	_	_	_
20	circadian	_	_	JJ	_	_	_	_	_
21	time-specific	_	_	JJ	_	_	_	_	_
22	manner	_	_	NN	_	_	_	_	_
23	.	_	_	.	_	_	_	_	_


1	Interestingly	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	the	_	_	DT	_	_	_	_	_
4	bHLH-O	_	_	NNP	_	_	_	_	_
5	proteins	_	_	NNS	_	_	_	_	_
6	members	_	_	NNS	_	_	_	_	_
7	(	_	_	-LRB-	_	_	_	_	_
8	class	_	_	NN	_	_	_	_	_
9	VI	_	_	NNP	_	_	_	_	_
10	,	_	_	,	_	_	_	_	_
11	Table	_	_	NN	_	_	_	_	_
12	1	_	_	CD	_	_	_	_	_
13	)	_	_	-RRB-	_	_	_	_	_
14	HEY	_	_	NNP	_	_	_	_	_
15	proteins	_	_	NNS	_	_	_	_	_
16	can	_	_	MD	_	_	_	_	_
17	function	_	_	VB	_	_	_	_	_
18	as	_	_	IN	_	_	_	_	_
19	transcription	_	_	NN	_	_	_	_	_
20	repressors	_	_	NNS	_	_	_	_	_
21	as	_	_	RB	_	_	_	_	_
22	well	_	_	RB	_	_	_	_	_
23	as	_	_	IN	_	_	_	_	_
24	transcription	_	_	NN	_	_	_	_	_
25	activators	_	_	NNS	_	_	_	_	_
26	.	_	_	.	_	_	_	_	_


1	They	_	_	PRP	_	_	_	_	_
2	were	_	_	VBD	_	_	_	_	_
3	shown	_	_	VBN	_	_	_	_	_
4	to	_	_	TO	_	_	_	_	_
5	bind	_	_	VB	_	_	_	_	_
6	directly	_	_	RB	_	_	_	_	_
7	DNA	_	_	NN	_	_	_	_	_
8	and	_	_	CC	_	_	_	_	_
9	interact	_	_	VB	_	_	_	_	_
10	with	_	_	IN	_	_	_	_	_
11	histone	_	_	NN	_	_	_	_	_
12	deacetylases	_	_	NNS	_	_	_	_	_
13	and	_	_	CC	_	_	_	_	_
14	other	_	_	JJ	_	_	_	_	_
15	TFs	_	_	NNS	_	_	_	_	_
16	.	_	_	.	_	_	_	_	_


1	On	_	_	IN	_	_	_	_	_
2	the	_	_	DT	_	_	_	_	_
3	other	_	_	JJ	_	_	_	_	_
4	hand	_	_	NN	_	_	_	_	_
5	,	_	_	,	_	_	_	_	_
6	gene	_	_	NN	_	_	_	_	_
7	activation	_	_	NN	_	_	_	_	_
8	by	_	_	IN	_	_	_	_	_
9	HEY	_	_	UH	_	_	_	_	_
10	is	_	_	VBZ	_	_	_	_	_
11	regulated	_	_	VBN	_	_	_	_	_
12	in	_	_	IN	_	_	_	_	_
13	an	_	_	DT	_	_	_	_	_
14	indirect	_	_	JJ	_	_	_	_	_
15	way	_	_	NN	_	_	_	_	_
16	.	_	_	.	_	_	_	_	_


1	Multiple	_	_	JJ	_	_	_	_	_
2	HEY	_	_	UH	_	_	_	_	_
3	binding	_	_	NN	_	_	_	_	_
4	sites	_	_	NNS	_	_	_	_	_
5	located	_	_	VBN	_	_	_	_	_
6	downstream	_	_	RB	_	_	_	_	_
7	and	_	_	CC	_	_	_	_	_
8	close	_	_	JJ	_	_	_	_	_
9	to	_	_	TO	_	_	_	_	_
10	the	_	_	DT	_	_	_	_	_
11	transcriptional	_	_	JJ	_	_	_	_	_
12	start	_	_	NN	_	_	_	_	_
13	site	_	_	NN	_	_	_	_	_
14	,	_	_	,	_	_	_	_	_
15	resulted	_	_	VBD	_	_	_	_	_
16	in	_	_	IN	_	_	_	_	_
17	a	_	_	DT	_	_	_	_	_
18	hypothesis	_	_	NN	_	_	_	_	_
19	that	_	_	IN	_	_	_	_	_
20	HEY	_	_	UH	_	_	_	_	_
21	influence	_	_	VBP	_	_	_	_	_
22	the	_	_	DT	_	_	_	_	_
23	pausing/elongation	_	_	NN	_	_	_	_	_
24	switch	_	_	NN	_	_	_	_	_
25	of	_	_	IN	_	_	_	_	_
26	Pol	_	_	NNP	_	_	_	_	_
27	II	_	_	NNP	_	_	_	_	_
28	.	_	_	.	_	_	_	_	_


1	Interestingly	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	though	_	_	IN	_	_	_	_	_
4	most	_	_	JJS	_	_	_	_	_
5	of	_	_	IN	_	_	_	_	_
6	TFs	_	_	NNS	_	_	_	_	_
7	stimulate	_	_	VBP	_	_	_	_	_
8	transcription	_	_	NN	_	_	_	_	_
9	initiation	_	_	NN	_	_	_	_	_
10	,	_	_	,	_	_	_	_	_
11	MYC	_	_	NNP	_	_	_	_	_
12	(	_	_	-LRB-	_	_	_	_	_
13	class	_	_	NN	_	_	_	_	_
14	III	_	_	NNP	_	_	_	_	_
15	,	_	_	,	_	_	_	_	_
16	Table	_	_	NN	_	_	_	_	_
17	1	_	_	CD	_	_	_	_	_
18	)	_	_	-RRB-	_	_	_	_	_
19	was	_	_	VBD	_	_	_	_	_
20	shown	_	_	VBN	_	_	_	_	_
21	to	_	_	TO	_	_	_	_	_
22	stimulate	_	_	VB	_	_	_	_	_
23	transcription	_	_	NN	_	_	_	_	_
24	elongation	_	_	NN	_	_	_	_	_
25	by	_	_	IN	_	_	_	_	_
26	recruitment	_	_	NN	_	_	_	_	_
27	of	_	_	IN	_	_	_	_	_
28	the	_	_	DT	_	_	_	_	_
29	elongation	_	_	NN	_	_	_	_	_
30	factor	_	_	NN	_	_	_	_	_
31	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	presented	_	_	VBN	_	_	_	_	_
3	studies	_	_	NNS	_	_	_	_	_
4	indicate	_	_	VBP	_	_	_	_	_
5	that	_	_	IN	_	_	_	_	_
6	the	_	_	DT	_	_	_	_	_
7	crucial	_	_	JJ	_	_	_	_	_
8	role	_	_	NN	_	_	_	_	_
9	of	_	_	IN	_	_	_	_	_
10	the	_	_	DT	_	_	_	_	_
11	bHLH	_	_	NN	_	_	_	_	_
12	proteins	_	_	NNS	_	_	_	_	_
13	in	_	_	IN	_	_	_	_	_
14	maintaining	_	_	VBG	_	_	_	_	_
15	transcriptional	_	_	JJ	_	_	_	_	_
16	regulation	_	_	NN	_	_	_	_	_
17	of	_	_	IN	_	_	_	_	_
18	important	_	_	JJ	_	_	_	_	_
19	developmental	_	_	JJ	_	_	_	_	_
20	(	_	_	-LRB-	_	_	_	_	_
21	e.	_	_	FW	_	_	_	_	_
22	g.	_	_	FW	_	_	_	_	_
23	,	_	_	,	_	_	_	_	_
24	cell	_	_	NN	_	_	_	_	_
25	differentiation	_	_	NN	_	_	_	_	_
26	)	_	_	-RRB-	_	_	_	_	_
27	and	_	_	CC	_	_	_	_	_
28	oncogenic	_	_	JJ	_	_	_	_	_
29	pathways	_	_	NNS	_	_	_	_	_
30	is	_	_	VBZ	_	_	_	_	_
31	dependent	_	_	VBN	_	_	_	_	_
32	on	_	_	IN	_	_	_	_	_
33	the	_	_	DT	_	_	_	_	_
34	multiple	_	_	JJ	_	_	_	_	_
35	interactions	_	_	NNS	_	_	_	_	_
36	with	_	_	IN	_	_	_	_	_
37	basal	_	_	JJ	_	_	_	_	_
38	transcriptional	_	_	JJ	_	_	_	_	_
39	machinery	_	_	NN	_	_	_	_	_
40	.	_	_	.	_	_	_	_	_

